Proteinuria is strongly associated with kidney disease progression but the mechanisms underlying podocyte handling of serum proteins such as albumin and IgG remain to be elucidated. We have previously shown that albumin and IgG are transcytosed by podocytes in vitro. In other epithelial cells, the neonatal Fc receptor (FcRn) is required to salvage albumin and IgG from the degradative pathway thereby allowing these proteins to be transcytosed or recycled.
Introduction
Proteinuria is an independent marker of kidney disease progression and is widely used clinically as a biomarker of kidney dysfunction (1, 2). Proteinuria is both a consequence of kidney damage and damages the glomerulus and tubules directly by increasing production of pro-inflammatory cytokines and promoting fibrosis (1, [3] [4] [5] . Both the glomerulus and the proximal tubules are involved in the renal handling of serum proteins but the molecular mechanisms remain to be fully elucidated. The primary barrier to filtration of large plasma proteins into the urine is the glomerular filtration barrier (GFB) which consists of three layers -a fenestrated endothelium, the glomerular basement membrane and the podocyte (6) . The podocyte is a specialized epithelial cell containing a large cell body and multiple processes which ramify to form smaller processes. Paracellular passage of large serum proteins is prevented by the slit diaphragm which extends between the foot processes of neighboring podocytes and precludes filtration of proteins ~ 70 kDa or larger. The precise amount of albumin filtered through the GFB is a contested topic (7, 8) . By even the most conservative estimates, ~ 4 g albumin a day transit the GFB (9) . The amount of IgG that traverses the glomerular filtration barrier is unknown.
Podocytes have been shown to take up albumin in vitro and in vivo (4, 10, 11) . Using in vitro assays, we have previously shown that podocytes endocytose albumin and that most is transcytosed, with a smaller amount sent to the lysosome for degradation (12) . These findings have been confirmed in vivo using intravital multiphoton microscopy in rats (11) . In other epithelial cells, including those in the renal proximal tubule, the neonatal Fc receptor (FcRn) is required to prevent albumin and IgG from entering the degradative pathway, thereby allowing albumin to be recycled or transcytosed (13) (14) (15) (16) . FcRn, has homology to major histocompatibility complex class I and binds albumin and IgG at pH 6-6.5 but has minimal affinity for these 4 proteins at neutral pH (17) . Within the adult kidney, FcRn is expressed in podocytes, vascular endothelial cells and the proximal tubule (18) . The physiologic role of FcRn in albumin trafficking in podocytes is unknown.
Akilesh et al. demonstrated that the neonatal Fc receptor is required to prevent the intraglomerular accumulation of IgG in mice (19) . These studies were performed in global FcRn knockout (KO) mice which manifest hypoalbuminemia and hypogammaglobulinemia. Plasma levels of albumin and IgG are 50% (16) and 80-90% (20) lower respectively in global FcRn KO compared to wild type (WT) mice. Thus podocytes in the global KO are exposed to significantly less albumin and IgG than WT mice which might alter trafficking pathways.
Here we use in vitro assays and podocyte-specific FcRn knockout mice to directly examine the role of FcRn in albumin and IgG trafficking in podocytes. Creation of podocyte-specific FcRn KO mice allowed for the examination of intraglomerular trafficking of albumin and IgG in mice that have normal serum levels of these proteins, permitting direct assessment of FcRn mediated trafficking of albumin and IgG in podocytes.
Results
Establishing WT and FcRn KO podocyte cell lines. In order to directly investigate the role of FcRn in albumin and IgG trafficking in podocytes, we isolated podocytes from WT and global FcRn KO mice and created conditionally immortalized cell lines by transforming primary podocytes with the thermosensitive SV40 T antigen (21) . Differentiated WT and FcRn KO podocytes expressed the podocyte markers podocin and Wilms tumor 1 (WT1) ( Figure 1A ) and
FcRn KO podocytes had minimal FcRn mRNA as assessed by qPCR ( Figure 1B ). FcRn knockout did not impair albumin or IgG uptake in podocytes ( Figure 1C ). 5 FcRn KO impairs IgG trafficking but not albumin trafficking in vitro. To examine IgG and albumin trafficking in vitro, differentiated WT and FcRn KO podocytes were loaded with albumin or IgG at 4 o C (a temperature that allows surface binding of albumin or IgG but inhibits endocytosis) or 37 o C (permits endocytosis), washed well after loading and harvested immediately or at the times indicated in Figure 2 . Leupeptin, a lysosomal enzyme inhibitor, was also used to examine the effects of blocking lysosomal degradation on albumin and IgG trafficking in WT and FcRn KO podocytes. In WT podocytes loaded with IgG at 37°C, there was a decrease in the amount of IgG remaining in the cells after 30 minutes incubation in Ringer solution ( Figure 2A ). Inhibition of lysosomal degradation with leupeptin did not significantly increase the amount of IgG remaining in WT podocytes after 30 minutes incubation in Ringer solution, suggesting that monomeric IgG is not trafficked to the lysosome. In contrast to WT podocytes, the amount of IgG remaining intracellularly in FcRn KO podocytes 30 minutes after loading with IgG was not significantly decreased, suggesting impairment in IgG transcytosis in the KO (Figure 2A ).
Albumin trafficking in WT and FcRn KO podocytes was examined by loading podocytes with FITC-labeled albumin, washing the podocytes very well and then assessing how much FITCalbumin remained in the podocytes immediately after washing or after 60 minutes in Ringer solution ± leupeptin to inhibit lysosomal degradation. Podocytes were assessed after 60 min as initial studies demonstrated that albumin is trafficked more slowly than IgG. As shown in Figure   2B , in both WT and FcRn KO podocytes loaded with FITC-albumin at 37 o C there was a significant decrease in the amount of albumin remaining in the cells 60 minutes after incubation in Ringer solution. Thus, knockout of FcRn did not impair albumin trafficking in podocytes in 6 vitro. In both WT podocytes, there was a trend towards increased albumin accumulation in leupeptin treated cells at t= 60 minutes, 37° C but this was not significant Podocyte-specific FcRn KO mice. In order to determine whether the differential trafficking of albumin and IgG in podocytes lacking FcRn occurred in vivo, we generated podocyte-specific Figure 3A ). There was no difference in the urinary albumin to creatinine ratio in podocyte-specific FcRn KO mice versus control at 3, 6 and 12 months ( Figure 3B ).
Podocyte-specific KO of FcRn results in IgG accumulation in the glomerulus. We used immunofluorescence staining to examine whether lack of FcRn in podocytes results in albumin or IgG accumulation in the glomerulus as mice age. There was no significant difference in IgG accumulation in the glomeruli of podocyte-specific FcRn KO versus control mice at 3 months of age (mean IgG fluorescence/glomerular area 3.9 ± 0.5 vs 5.1 ± 0.4, p = NS; Figure 4A ). By 6 months of age, podocyte-specific FcRn KO mice had a significant increase in glomerular IgG compared to controls (5.7 ± 0.3 vs 4.1 ± 0.2, p < 0.05). At 12 months of age there was a statistically significant increase in the amount of IgG present in the glomerulus in podocytespecific FcRn KO compared to controls (9.4 ± 0.5 vs 5.6 ± 0.5, p < 0.0001).
Podocyte-specific KO of FcRn results in minimal intraglomerular albumin accumulation.
When mean albumin intensity per glomerulus was measured, there was no significant difference in albumin accumulation in the glomeruli of 3 month, 6 month or 12 month old versus podocytespecific FcRn KO versus control mice ( Figure 4B ). Interestingly, there was a significant time 7 dependent decrease in intraglomerular albumin accumulation with 12 month old control and podocyte-specific FcRn KO mice exhibiting a significant decrease in albumin accumulation within the glomerulus compared to the respective 3 month old mice (mean albumin fluorescence/glomerular area for 12 month versus 3 month old mice 1.5 ± 0.1 vs 2.5 ± 0.1 for controls, p < 0.0001 and 1.8 ± 0.1 vs 2.3 ± 0.1 for KO, p < 0.01). The lack of albumin detection within the glomerulus was not due to an inability to stain for albumin as albumin within the blood vessels surround the glomerulus was readily detected ( Figure 4B ).
Podocyte-specific KO of FcRn leads to increased mesangial:glomerular area ratio. By 6 months of age, podocyte-specific FcRn KO mice had a significant decrease in glomerular area compared to control mice (1703 ± 62.7 um 2 2198 ± 92.9 um 2 , p < 0.0001) and a significant increase in the mesangial to glomerular area (0.41 ± 0.01 vs 0.27 ± 0.01, p < 0.0001; Figure 5A ). By 12 months of age, there was a further significant increase in the mesangial/glomerular area in the podocytespecific FcRn KO compared to controls (0.46 ± 0.01 vs 0.35 ± 0.01, p < 0.0001), with a resultant increase in the glomerular area in the KO to close to that of control ( Figure 5B ). To further examine the mesangial expansion seen in the podocyte-specific FcRn KO mice, we examined the glomerular expression of α-smooth muscle actin (α-SMA), a marker of activated mesangial cells (22) . We found an increase in glomerular α-SMA actin expression by 3 months in podocyte-specific FcRn KO versus control which was statistically significant by 6 and 12 month months (α-SMA intensity/glomerular area for 3 month KO vs control 3.2 ± 0.3 vs 1.2 ± 0.1; for 6 month KO vs control 7.5 ± 0.5 vs 4.0 ± 0.3, p < 0.01; for 12 month KO versus control 16.3 ± 1.0 vs 5.6 ± 0.3, p < 0.0001, Figure 6 ).
Discussion
Proteinuria is a common clinical marker of kidney damage and is strongly associated with progression of kidney disease (2, 23) . The mechanisms underlying renal handling of serum proteins such as albumin and IgG remain to be fully elucidated. Human and animal studies have shown podocyte vacuolization in proteinuric kidney diseases and albumin and IgG have been shown to colocalize with podocyte vacuoles (5, 10, (24) (25) (26) (27) (28) (29) . Previously, we have shown that cultured podocytes endocytose albumin and that the majority of endocytosed albumin is transcytosed. Here we extend our findings to an in vivo model and also examine podocyte handling of IgG. To our knowledge, this is the first systematic concurrent examination of podocyte albumin and IgG trafficking in podocytes.
In renal proximal tubular cells, FcRn is required for salvaging albumin and IgG from the degradative pathway and transcytosing these proteins from the apical cell surface to the basolateral side (15) . Others have shown that injection of an anti-FcRn antibody reduces proteinuria in nephrotic rats (26) and that global FcRn KO mice accumulate IgG within the glomerulus by 6 months of age (19) . Our study, however, is the first to directly demonstrate the role of FcRn in albumin and IgG handling in cell culture and in an in vivo model in which only podocytes lack FcRn. Our studies demonstrate that albumin and IgG are differentially handled by podocytes in vitro and in vivo. Lack of FcRn in cultured podocytes did not impair albumin handling acutely. In vivo, lack of FcRn did not result in significant intraglomerular accumulation of albumin. Interestingly, mice had significantly less intraglomerular albumin accumulation at 12 months compared to 3 months in both podocyte-specific FcRn KO animals and controls. Lack of intraglomerular albumin accumulation in podocyte-specific FcRn KO mice was not due to technical issues with staining as albumin could be seen in the peritubular and periglomerular An interesting finding of the present study is that podocyte-specific knockout of FcRn leads to mesangial expansion in the KO mice as they age as well as increased expression of α-smooth muscle actin within the mesangial regions of the glomerulus, suggesting activation of mesangial cells with intraglomerular IgG accumulation. The mechanisms underlying how knockout of a trafficking protein in a podocyte can lead to an expansion of mesangial area and increased expression of a-SMA remain to be further investigated.
In summary we have directly examined the role of FcRn in albumin and IgG trafficking in poodcytes and found that FcRn-mediated trafficking of these proteins differs. Our findings suggest that intra-podocyte trafficking pathways are complex and that disruption of normal trafficking pathways in podocytes is deleterious.
Methods:
Cell culture: Generation of conditionally immortalized WT and FcRn KO podocytes: Podocytes were isolated from wild type or global FcRn KO mice as previously described (30) . Primary podocytes were immortalized using a thermosensitive SV40 T antigen as previously described (21) . Briefly, media containing viral particles was collected from the viral producer line plpcx SVtsa58 (kindly provided by Dr. Parmjit Jat) and applied to primary WT or FcRn KO podocytes.
The plpcs SVtsa58 viral producer line encodes the thermolabile tsA58 LT antigen and G418
resistance. Podocytes were selected using G418. After selection, podocytes were allowed to replicate at 33 o C. To induce differentiation, podocytes were placed at 37 o C for 8 -10 days. To verify expression of podocyte markers, podocytes were stained with podocin or WT1.
In vitro trafficking assay: The in vitro albumin and IgG trafficking experiments were performed as previously described (12) . Briefly, WT or FcRn KO podocytes were loaded with 1.5 mg/ml Male mice were used for all experiments. All procedures involving animals were performed using protocols approved by the Institutional Animal Care and Use Committee at the University of Colorado, Denver, protocol number 00085. Animals were euthanized using pentobarbital.
Urine albumin was measured using the Albuwell assay (Exocell), urine creatinine was measured using the assay and BUN was measured on an Alpha Wasserman auto analyzer. Serum albumin was measured by ELISA (Abcam) as was serum IgG (Affymetrix).
Immunofluorescence: Confocal microscopy images were acquired using Zeiss 780 laserscanning confocal/multiphoton-excitation fluorescence microscope with a 34-Channel GaAsP QUASAR Detection Unit and non-descanned detectors for two-photon fluorescence (Zeiss, Thornwood, NY). The imaging settings were initially defined empirically to maximize the signal-to-noise ratio and to avoid saturation. In comparative imaging, the settings were kept constant between samples. Images were obtained with a Zeiss C-Apochromat 40x/1.2NA Korr FCS M27 water-immersion lens objective. The illumination for imaging was provided by a 13 30mW Argon Laser using excitation at 488 nm, HeNe 5mW (633 nm) and 1mW (543 nm). Figure 2A and B.
